Market revenue in 2021 | USD 99.3 million |
Market revenue in 2030 | USD 665.1 million |
Growth rate | 23.5% (CAGR from 2021 to 2030) |
Largest segment | Oncology |
Fastest growing segment | CVD |
Historical data covered | 2018 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.36% in 2021. Horizon Databook has segmented the Latin America ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
In Latin America, 80% of the population lives in metropolitan cities. Mega cities such as Sao Paulo, Buenos Aires, and Mexico City have a large patient pool. Although long regulatory timelines in Latin America are a drawback, the time saved in patient recruitment compensates for it.
In addition to patient recruitment, patient retention is also very high due to cooperative patient-physician relationship. Lower cost, highly qualified investigators, medical personnel, and study coordinators with GCP-compliant knowledge contribute to higher clinical trial success rate.
Moreover, Mexico and Brazil are expected to witness lucrative market growth due to cost advantage over developed economies such as the U.S. and European countries including Germany. These factors are likely to support adoption of advanced technological solutions in clinical research in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America ai-based clinical trials solution provider market, including forecasts for subscribers. This continent databook contains high-level insights into Latin America ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account